NCT00003816 arm group b12fb9ea8ea37c052a94ab1aecdaab3a [clinicaltrials_resource:NCT00003816/arm-group/b12fb9ea8ea37c052a94ab1aecdaab3a]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00003816 arm group b12fb9ea8ea37c052a94ab1aecdaab3a [clinicaltrials_resource:NCT00003816/arm-group/b12fb9ea8ea37c052a94ab1aecdaab3a]
Bio2RDF identifier
NCT00003816/arm-group/b12fb9ea8ea37c052a94ab1aecdaab3a
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 2fb9ea8ea37c052a94ab1aecdaab3a
description [clinicaltrials_vocabulary:description]
Patients receive cyclophospham ...... twice daily on days -3 to -1.
identifier
clinicaltrials_resource:NCT00003816/arm-group/b12fb9ea8ea37c052a94ab1aecdaab3a
title
NCT00003816 arm group b12fb9ea8ea37c052a94ab1aecdaab3a
@en
type
label
NCT00003816 arm group b12fb9ea ...... fb9ea8ea37c052a94ab1aecdaab3a]
@en